Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Keith Alan Johnson, M.D.

Co-Author

This page shows the publications co-authored by Keith Johnson and Bradford Dickerson.
Connection Strength

1.459
  1. Flortaucipir tau PET imaging in semantic variant primary progressive aphasia. J Neurol Neurosurg Psychiatry. 2018 10; 89(10):1024-1031.
    View in: PubMed
    Score: 0.188
  2. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease. JAMA Neurol. 2017 04 01; 74(4):427-436.
    View in: PubMed
    Score: 0.181
  3. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases. JAMA Neurol. 2016 Nov 01; 73(11):1334-1341.
    View in: PubMed
    Score: 0.176
  4. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016 Jan; 79(1):110-9.
    View in: PubMed
    Score: 0.166
  5. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med. 2010 Mar; 12(1):27-43.
    View in: PubMed
    Score: 0.111
  6. Cortical thickness across the lifespan in a Colombian cohort with autosomal-dominant Alzheimer's disease: A cross-sectional study. Alzheimers Dement (Amst). 2021; 13(1):e12233.
    View in: PubMed
    Score: 0.062
  7. 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome. Brain. 2021 02 12; 144(1):266-277.
    View in: PubMed
    Score: 0.059
  8. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010 Jun 01; 107(22):10256-61.
    View in: PubMed
    Score: 0.056
  9. Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum. Neuropsychologia. 2020 03 16; 140:107391.
    View in: PubMed
    Score: 0.055
  10. Topography of cortical thinning in the Lewy body diseases. Neuroimage Clin. 2020; 26:102196.
    View in: PubMed
    Score: 0.055
  11. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy. Neuroimage Clin. 2019; 23:101889.
    View in: PubMed
    Score: 0.053
  12. Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms. PLoS One. 2018; 13(1):e0191345.
    View in: PubMed
    Score: 0.048
  13. 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. Ann Neurol. 2017 Oct; 82(4):622-634.
    View in: PubMed
    Score: 0.047
  14. Case 1-2017. A 70-Year-Old Woman with Gradually Progressive Loss of Language. N Engl J Med. 2017 01 12; 376(2):158-167.
    View in: PubMed
    Score: 0.045
  15. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Ann Neurol. 2017 Jan; 81(1):117-128.
    View in: PubMed
    Score: 0.045
  16. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol. 2015 Nov; 78(5):787-800.
    View in: PubMed
    Score: 0.041
  17. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol. 2015 Feb; 41(1):24-46.
    View in: PubMed
    Score: 0.039
  18. You don't say: dynamic aphasia, another variant of primary progressive aphasia? J Alzheimers Dis. 2013; 34(1):139-44.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.